Science Explorer Back to mapMap
Institution · CancerCare Manitoba

Most cited papers from CancerCare Manitoba

What are the most cited papers from CancerCare Manitoba?

The most cited paper from CancerCare Manitoba is "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (Daniel J. Klionsky et al., 2016), with 6,023 citations. Next come "Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America" (3,477) and "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (2,743).

Showing 50 of 60 papers. Every paper with more than 338 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
2 Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases 22 Jan 2011 3,477
3 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
4 Applications of Support Vector Machine (SVM) Learning in Cancer Genomics Shujun Huang, Nianguang Cai, P. Pacheco et al. · Cancer Genomics & Proteomics Open access 2 Jan 2018 1,562
5 Improving the Quality of Spiritual Care as a Dimension of Palliative Care: The Report of the Consensus Conference Christina M. Puchalski, BETTY ROLLING FERRELL, Rose Virani et al. · Journal of Palliative Medicine Open access Oct 2009 1,559
6 Cancer risk in patients with inflammatory bowel disease Charles Noah Bernstein, James Blanchard, Erich V. Kliewer et al. · Cancer 2001 1,170
7 International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts Hervé Dombret et al. · Blood Open access 18 May 2015 1,168
8 Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Michel P. Coleman et al. · The Lancet Open access 22 Dec 2010 1,131
9 A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease Qingdong Guan · Journal of Immunology Research Open access Dec 2019 1,087
10 Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study Melina Arnold et al. · The Lancet Oncology Open access 11 Sep 2019 1,083
11 Dignity Therapy: A Novel Psychotherapeutic Intervention for Patients Near the End of Life Harvey Max Chochinov, Thomas F. Hack, Thomas H. Hassard et al. · Journal of Clinical Oncology 18 Aug 2005 1,036
12 Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial Johan A. Maertens et al. · The Lancet 15 Dec 2015 1,006
13 Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology Open access 21 Oct 2008 909
14 The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer Pamela Jean Goodwin et al. · New England Journal of Medicine Open access 13 Dec 2001 896
15 Comprehensive Analysis of Hypermutation in Human Cancer Brittany B. Campbell et al. · Cell Open access 19 Oct 2017 817
16 Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial Harvey Max Chochinov, Linda J. Kristjanson, WILLIAM S. BREITBART et al. · The Lancet Oncology Open access 8 Jul 2011 781
17 Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment Meghan B. Azad, Yongqiang Chen, Spencer Bruce Gibson · Antioxidants and Redox Signaling Oct 2008 767
18 Dignity in the terminally ill: a developing empirical model Harvey Max Chochinov, Thomas F. Hack, Susan McClement et al. · Social Science & Medicine Feb 2002 737
19 Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases Open access 4 Jan 2011 716
20 Apoptosis and cancer: mutations within caspase genes Saeid Ghavami, Mohammad Mostakhdem Hashemi, Sudharsana Rao Ande et al. · Journal of Medical Genetics Open access 7 Jun 2009 714
21 Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells Yongqiang Chen, Eileen McMillan‐Ward, Jiming Kong et al. · Cell Death and Differentiation 5 Oct 2007 691
22 Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation Ryan Zarychanski, Ahmed M Abou-Setta, Alexis Fournier Turgeon et al. · JAMA 19 Feb 2013 660
23 First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation Paul J. Martin, J. Douglas Rizzo, John R. Wingard et al. · Transplantation and Cellular Therapy Open access 14 Apr 2012 658
24 Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis Mélanie Drolet et al. · The Lancet Infectious Diseases ReviewOpen access 2 Mar 2015 648
25 Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial Jeff Porter Sharman et al. · The Lancet Open access Apr 2020 633
26 Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells Shumei Ma, Elizabeth S. Henson, Yongqiang Chen et al. · Cell Death and Disease Open access 21 Jul 2016 632
27 Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007 Sarah Walters et al. · Thorax Open access 11 Feb 2013 579
28 Sympathy, empathy, and compassion: A grounded theory study of palliative care patients’ understandings, experiences, and preferences Shane Sinclair, Kate Beamer, Thomas F. Hack et al. · Palliative Medicine Open access 17 Aug 2016 544
29 Transient Anomalous Diffusion of Telomeres in the Nucleus of Mammalian Cells Irena Bronstein, Yonatan Israel, Eldad Kepten et al. · Physical Review Letters Open access 2 Jul 2009 523
30 Dignity and the essence of medicine: the A, B, C, and D of dignity conserving care Harvey Max Chochinov · BMJ Open access 26 Jul 2007 514
31 Compassion: a scoping review of the healthcare literature Shane Sinclair, Jill M. Norris, Shelagh McConnell et al. · BMC Palliative Care Open access 19 Jan 2016 512
32 Combination Antifungal Therapy for Invasive Aspergillosis Kieren A. Marr, Haran T. Schlamm, Raoul Herbrecht et al. · Annals of Internal Medicine 19 Jan 2015 507
33 Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat Gloria E. Villalpando-Rodriguez, Spencer Bruce Gibson · Oxidative Medicine and Cellular Longevity Open access 2021 502
34 Preoperative Treatment of Locally Advanced Rectal Cancer Deborah Schrag et al. · New England Journal of Medicine Open access 4 Jun 2023 490
35 Changes in colorectal cancer incidence in seven high-income countries: a population-based study Marzieh Hosseini Araghi et al. · ˜The œLancet. Gastroenterology & hepatology Open access 16 May 2019 488
36 The Reduction in Colorectal Cancer Mortality After Colonoscopy Varies by Site of the Cancer Harminder Singh, Zoann Jane Nugent, Alain A. Demers et al. · Gastroenterology 21 Jun 2010 482
37 Dignity in the terminally ill: a cross-sectional, cohort study Harvey Max Chochinov, Thomas F. Hack, Thomas H. Hassard et al. · The Lancet Dec 2002 476
38 Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria Brahm H. Segal et al. · Clinical Infectious Diseases Open access 18 Jul 2008 473
39 Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis Ryan Zarychanski, Vincent Schulz, Brett L. Houston et al. · Blood Open access 24 Apr 2012 473
40 Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12 Michael Crump et al. · Journal of Clinical Oncology Open access 29 Sep 2014 468
41 Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy Subbareddy Maddika, Sudharsana Rao Ande, Soumya Panigrahi et al. · Drug Resistance Updates Open access Feb 2007 461
42 Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain Michael Verret, François Lauzier, Ryan Zarychanski et al. · Anesthesiology Open access 26 Jun 2020 455
43 Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species Yongqiang Chen, Eileen McMillan‐Ward, Jiming Kong et al. · Journal of Cell Science 21 Nov 2007 453
44 Rucaparib or Physician’s Choice in Metastatic Prostate Cancer Karim S. Fizazi et al. · New England Journal of Medicine Open access 16 Feb 2023 447
45 The Patient Dignity Inventory: A Novel Way of Measuring Dignity-Related Distress in Palliative Care Harvey Max Chochinov, Thomas H. Hassard, Susan McClement et al. · Journal of Pain and Symptom Management Open access 25 Jun 2008 434
46 The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy Philip S. Rosenberg · Blood Open access 24 Feb 2006 431
47 A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening Daniel C. Chung, Darrell M. Gray, Harminder Singh et al. · New England Journal of Medicine 13 Mar 2024 426
48 The communication goals and needs of cancer patients: a review Thomas F. Hack, Lesley Faith Degner, Patricia A. Parker · Psycho-Oncology 30 Sep 2005 408
49 Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial Meletios Athanasios Dimopoulos, Hartmut Goldschmidt, Rubén Niesvizky et al. · The Lancet Oncology 23 Aug 2017 406
50 Cancer stem cell markers in common cancers – therapeutic implications Thomas C. Klonisch, Emilia Wiecheć, Sabine Hombach‐Klonisch et al. · Trends in Molecular Medicine ReviewOpen access 4 Sep 2008 401

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.